0001062993-19-002781.txt : 20190702 0001062993-19-002781.hdr.sgml : 20190702 20190702144703 ACCESSION NUMBER: 0001062993-19-002781 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190701 FILED AS OF DATE: 20190702 DATE AS OF CHANGE: 20190702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wegman Toby CENTRAL INDEX KEY: 0001405128 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 19936731 MAIL ADDRESS: STREET 1: 4092 BOCAIRE BLVD. CITY: BOCA RATON STATE: FL ZIP: 33487 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2019-07-01 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001405128 Wegman Toby C/O BIOSPECIFICS TECHNOLOGIES CORP. 35 WILBUR STREET LYNBROOK NY 11563 1 0 1 0 Common Stock, $0.001 par value 2019-07-01 4 A 0 1890 0 A 1890 D Common Stock, $0.001 par value 945073 I See footnote Grant of restricted stock units under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan. These shares are held in trust on behalf of the reporting person. The reporting person is the trustee of the trust. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein. /s/ Toby Wgman, by Carl A. Valenstein, attorney-in-fact 2019-07-02